Sign in to view content

2-Year Outcomes From Randomized Trials of Anti-VEGF Treatments for Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)

Geeta A. Lalwani, MD

Video
Published 2018

Related

Novel Vascular Endothelial Growth-Factor A (VEGF-A) and Angiopoietin-2 (Ang-2) Bispecific Protein, RO-634, in Comparison to Aflibercept
Mark R. Barakat, MD
Annual Meeting Talks
2022
Episode 158: Journal Club with Dr. Ajay Kuriyan and Dr. Shriji Patel, IVR versus IVA for wet AMD, Protocol T subanalysis, CSR natural history
Jayanth Sridhar, MD
Member Podcasts
2018
Nd: YAG Capsulotomy is Associated with Sustained IOP Elevation in Patients Treated with Anti-VEGF Injections
ASSAF DOTAN, MD
Updates from the Field
2018

Category: Diabetic Retinopathy

See more